MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05079841 | ACTIVE_NOT_RECRUITING | PHASE4
933 participants

The Stimulation To Induce Mothers Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-11-15
Completion:
2028-11-30
Conditions
  • Oxytocin
  • Labor Pain
  • Induction of Labor Affected Fetus / Newborn
  • Physiologic Effects of Drugs
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT05053152 | ACTIVE_NOT_RECRUITING | PHASE2
194 participants

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-04-20
Completion:
2029-02-01
Conditions
  • Oligometastatic Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Prostate Ductal Adenocarcinoma
  • Prostate Intraductal Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
  • RADIATION
No Results Yet
NCT05047185 | TERMINATED | PHASE2
34 participants

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-04-19
Completion:
2025-06-30
Conditions
  • Hereditary Angioedema
  • Hereditary Angioedema Type I
  • Hereditary Angioedema Type II
  • Hereditary Angioedema Types I and II
  • Hereditary Angioedema Attack
  • Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
  • Hereditary Angioedema - Type 1
  • Hereditary Angioedema - Type 2
  • C1 Esterase Inhibitor Deficiency
  • C1 Inhibitor Deficiency
Interventions
  • DRUG
Results Available
NCT04895709 | RECRUITING | PHASE1/PHASE2
1109 participants

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-05-27
Completion:
2031-08-31
Conditions
  • Cervical Cancer
  • Gastric/Gastroesophageal Junction Adenocarcinoma
  • Microsatellite Stable Colorectal Cancer
  • Non-Small-Cell Lung Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Carcinoma, Renal Cell
  • Urothelial Carcinoma
  • Pancreatic Adenocarcinoma
  • Melanoma
  • Ovarian Neoplasms
  • Triple Negative Breast Neoplasms
Interventions
  • DRUG
No Results Yet
NCT04817969 | ACTIVE_NOT_RECRUITING | NA
240 participants

Persona Ti-Nidium Post-Market Clinical Follow-up

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-06-01
Completion:
2034-05-31
Conditions
  • Knee Pain Chronic
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Polyarthritis
  • Varus Deformity
  • Valgus Deformity
  • Flexion Deformity of the Knee
  • Avascular Necrosis
  • Patellofemoral Osteoarthritis
Interventions
  • DEVICE
No Results Yet
NCT04804644 | RECRUITING | PHASE3
200 participants

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-06-08
Completion:
2026-06-24
Conditions
  • Metastatic Lung Small Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Brain
  • Recurrent Lung Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • RADIATION
No Results Yet
NCT04804241 | RECRUITING | PHASE2
55 participants

Senicapoc in Alzheimer's Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2022-03-18
Completion:
2027-12-31
Conditions
  • Mild Cognitive Impairment
  • Alzheimer Disease
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT04725656 | COMPLETED | NA
125 participants

Concentration Impact Nicotine Salt

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2024-01-30
Completion:
2026-03-02
Conditions
  • Smoking Cessation
  • Vaping
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT04546009 | ACTIVE_NOT_RECRUITING | PHASE3
992 participants

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2020-10-09
Completion:
2026-01-30
Conditions
  • Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT04513717 | ACTIVE_NOT_RECRUITING | PHASE3
2753 participants

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-17
Start Date:
2021-01-21
Completion:
2033-12-31
Conditions
  • Prostate Adenocarcinoma
  • Stage III Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
  • RADIATION
No Results Yet
NCT04427033 | COMPLETED
52 participants

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-17
Start Date:
2019-12-06
Completion:
2024-01-18
Conditions
  • Hearing Loss
  • Hearing Loss, Conductive
  • Hearing Loss, Mixed
  • Hearing Loss, Unilateral
  • Hearing Loss, Bilateral
  • Hearing Loss, Sensorineural
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page